Origo Biopharma: Funding, Investors & Team (Aug 2026)
Origo Biopharma is a biotech company, specializes in research and development of immunotherapeutic products that address health disorders related to TGF-β signaling dysfunction, among this cancer and fibrosis.
Origo Biopharma has raised $2.3M across 1 funding round on record, the most recent an undisclosed round of $2.3M announced in Jul 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Origo Biopharma Company Profile and Key Stats
Latest funding round on record: Jul 2020.
Origo Biopharma Funding Rounds
Origo Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Origo Biopharma Funding Compared to Other Biotechnology Startups
Origo Biopharma's latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Origo Biopharma in Biotechnology and San Ciprián De Viñas
Companies Similar to Origo Biopharma
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Origo Biopharma Funding FAQs
What does Origo Biopharma do?
Origo Biopharma is a biotech company, specializes in research and development of immunotherapeutic products that address health disorders related to TGF-β signaling dysfunction, among this cancer and fibrosis.
How much funding has Origo Biopharma raised?
Origo Biopharma has raised $2.3M across 1 round on record. The most recent is an undisclosed round of $2.3M announced in Jul 2020.
When did Origo Biopharma last raise funding?
Origo Biopharma's most recent funding round on record is an undisclosed round of $2.3M, announced in Jul 2020.
Who is the CEO of Origo Biopharma?
Ramon Bosser is listed as CEO at Origo Biopharma.
Where is Origo Biopharma headquartered?
Origo Biopharma is based in San Ciprián De Viñas, Galicia, Spain.
How many employees does Origo Biopharma have?
Origo Biopharma is in the 1-10 employee band.
How does Origo Biopharma's funding compare to other Biotechnology startups?
Origo Biopharma's latest round of $2.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Origo Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Origo Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.